Malignant Melanoma of the Tongue: A Scoping Review
- PMID: 40003600
- PMCID: PMC11856353
- DOI: 10.3390/life15020191
Malignant Melanoma of the Tongue: A Scoping Review
Abstract
Malignant melanoma of the tongue is a rare and highly aggressive neoplasm, constituting less than 2% of oral melanomas. Due to its rarity and atypical clinical presentation, diagnosis and management pose significant challenges. This study provides a scoping review of research on melanoma of the tongue to determine the available data on the epidemiology, clinical features, histopathological characteristics, treatment strategies, and outcomes of this malignancy. Our literature search identified papers published from 1941 to 2024, and 47 individual cases were analyzed. The mean age at diagnosis was 58.6 years, with a male predominance (58.1%). Lesions were most frequently located on the body and lateral borders of the tongue. A high percentage (38.5%) presented with distant metastases at diagnosis, commonly involving the lungs and brain. Histopathological examination highlighted spindle cell morphology in many cases, with immunohistochemical markers such as HMB-45 and S-100 proving essential for diagnosis. Wide local excision with or without neck dissection was the primary treatment, though recurrence rates remained high (20.5%). Despite aggressive management, overall outcomes were poor, reflecting the melanoma's advanced stage at diagnosis in most cases. This scoping review underscores the need for heightened clinical suspicion, particularly for pigmented or ulcerative lesions of the tongue. Early diagnosis, multidisciplinary management, and further research into the genetic and molecular mechanisms underlying tongue melanoma are crucial to improve outcomes for this rare and aggressive disease.
Keywords: malignant melanoma; mucosal melanoma; oral neoplasms; review; tongue melanoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.Acta Dermatovenerol Croat. 2018 Apr;26(1):64-67. Acta Dermatovenerol Croat. 2018. PMID: 29782304 Review.
-
Recurrent Malignant Melanoma on the Tongue: A Case Report and Review of the Literature.Cancer Rep (Hoboken). 2025 May;8(5):e70215. doi: 10.1002/cnr2.70215. Cancer Rep (Hoboken). 2025. PMID: 40344340 Free PMC article. Review.
-
[Primitive malignant melanoma of the base of the tongue].Acta Otorhinolaryngol Ital. 1996 Aug;16(4):371-4. Acta Otorhinolaryngol Ital. 1996. PMID: 9082832 Italian.
-
Primary malignant melanoma of the tongue.Chang Gung Med J. 2002 Nov;25(11):764-8. Chang Gung Med J. 2002. PMID: 12553365
-
Clinical patterns and outcomes of patients affected by primary malignant melanoma of the oral mucosa: A European multicenter retrospective chart review.J Craniomaxillofac Surg. 2025 May;53(5):439-445. doi: 10.1016/j.jcms.2025.01.012. Epub 2025 Jan 24. J Craniomaxillofac Surg. 2025. PMID: 39863451
References
-
- Kirkwood J.M., Ibrahim J.G., Sosman J.A., Sondak V.K., Agarwala S.S., Ernstoff M.S., Rao U. High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared with the GM2-KLH/QS-21 Vaccine in Patients with Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801. J. Clin. Oncol. 2001;19:2370–2380. doi: 10.1200/JCO.2001.19.9.2370. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources